Sacubitril/valsartan improves cardiac function in Chinese patients with heart failure: a real‐world study

AIMS: Sacubitril/valsartan significantly reduced heart failure (HF) hospitalization and cardiovascular mortality in a randomized controlled trial. However, little is known about real‐world efficacy and safety of sacubitril/valsartan in Chinese patients with HF with reduced ejection fraction (HFrEF)....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenwen, Liu, Yanlin, Li, Yuanmin, Dang, Heqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497197/
https://www.ncbi.nlm.nih.gov/pubmed/34155812
http://dx.doi.org/10.1002/ehf2.13491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497197/
https://www.ncbi.nlm.nih.gov/pubmed/34155812
http://dx.doi.org/10.1002/ehf2.13491

Ejemplares similares